(Q45122865)

English

Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome

scientific article published on 21 October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Mizoribine oral pulse therapy for steroid-dependent nephrotic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Yukihiko Kawasaki

1

object named as

Yukihiko Kawasaki

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

6

object named as

Hitoshi Suzuki

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

author name string

Junzo Suzuki

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ai Takahashi

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Masato Isome

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Ruriko Nozawa

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

21 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Pediatric Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

96-98

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

A multicenter trial of mizoribine compared with placebo in children with frequently relapsing nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mizoribine and mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetic study of mizoribine in renal transplantation patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mizoribine in steroid-dependent nephrotic syndrome of childhood

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mizoribine oral pulse therapy for a patient with severe lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mizoribine as an effective combined maintenance therapy with prednisolone in child-onset systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New immunosuppressive drugs in organ transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/15503173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00467-004-1647-1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45122865&oldid=2207108148"